Sail Biomedicines
Amulya Kaza is an experienced associate scientist currently working at Sail Biomedicines, where responsibilities include developing circular RNA-based monoclonal antibody products for serious infectious diseases. Previously, Amulya served as a senior research associate and research associate 2, applying a circular RNA platform to various therapeutic modalities, such as targeting intracellular liver targets and developing fragment antibodies. Prior experience includes advancing gene editing programs for muscular dystrophy at Vertex Pharmaceuticals and contributing to rare neuromuscular disease drug development at Duke University's Pratt School of Engineering. Amulya holds a Master's degree in Biomedical Engineering from Duke University and a Bachelor of Technology in Mechanical Engineering from Delhi Technological University.
Sail Biomedicines
We work at the frontier of programmable medicines. We power our bioplatform and product candidates by harnessing evolution and AI. We operate with purpose and urgency on behalf of people everywhere. We aim to generate life-changing impact for the world.